Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cardiac Arrhythmia Monitoring Devices Market

  • MAR2978995
  • 212 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Cardiac Arrhythmia is a condition where the heartbeat is irregular, too fast or too slow. Normal heart rate is 72 beats per min. A heart rate of 100 beats per minute and 60 beats per min is known as tachycardia and bradycardia respectively. Although it is not serious in most of the cases, sometimes it can cause a stroke or heart failure. Arrhythmia monitoring is done to identify the type and causes of irregular heartbeat. These tests include Electrocardiograph(ECG) and Electrophysiology (EP) testing.

End User/Technology

Nerve and muscle are electrically active, and the heart also produces electrical signals. Due to the conductivity of human body, the potential from the excitable cells of the heart is transferred to the body surface.Chloride gel or saline solution is used to transfer the potential to the sensor. Electrodes on different sides of the heart measure different activities of the heart. ECG gives the potential difference between the different regions. Subacute patient monitoring and implantable loop recorders are used to record the activity over the short and long duration of time respectively.The cardiac arrhythmia monitoring devices market will reach 27.8 billion USD by 2021.

Market Dynamics

Nowadays, consumption of unhealthy food items, smoking, excessive alcohol intake is major reasons for cardiac diseases. Asedentary lifestyle like lack of exercise, children sitting glued to TV sets or computers instead of going out for physical activity have contributed to obesity and cardiac problems in children. Upgradation of technology and government grants for research on heart diseases is a significant market driver. A major challenge in the devices market is the lack of people with the required technical know-how to operate these devices.

Market segmentation

Based onend-user:

--> Hospitals

--> Clinics

--> Home-Care Centers

Based on geography

--> Asia-Pacific

--> Europe

--> North America

--> Latin America

--> Middle-East and Africa

Based onproduct type

--> 1 Channel

--> 2 Channel

--> 3 Channel

--> 12 Channel

--> Others

Segmentation by Monitoring Device Type

--> Implantable Cardiac Monitors

--> Resting ECG Devices

--> ECG Stress Test Devices

--> Mobile Cardiac Telemetry Monitors

--> Ambulatory ECG

--> Holter Monitors

--> Loop Recorders

--> Other Cardiac Monitoring Devices

Regional/Geographic Analysis

American cardiac patients in the age group of 65-80 years show a combination of supraventricular and ventricular arrhythmia. So, the demand for the monitoring devices will be highest in US and Canada.High costs and dependency on quality signal is a major hindrance to large-scale adoption of monitoring devices in the Asia-pacific region. The increasing use of telecardiography and the portability of the monitoring devices are major reasons for success in this region. Smart cardiac monitors are also in high demand in GCC.

Key Players

--> Biotelemetry

--> Cardiac Science Corp

--> Cardiocom

--> Cardionet

--> GE Healthcare

The report contains comprehensive analysis on:

--> Cardiac Arrhythmia Monitoring Devices Market Segments

--> Cardiac Arrhythmia Monitoring Devices Market Drivers, Restraints and Opportunities

--> Cardiac Arrhythmia Monitoring Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Chain

--> Cardiac Arrhythmia Monitoring Devices Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Feed Software Market includes

--> North America

-- >> US and Canada

--> Latin America

-- >> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

-- >> EU5 (Germany, France, Italy, Spain, U.K.)

-- >> Nordic Countries (Denmark, Finland, Norway, and Sweden)

-- >> Benelux (Belgium, The Netherlands, and Luxembourg)

-- >> Rest of Western Europe

--> Eastern Europe

-- >> Russia

-- >> Poland

-- >> Rest of Eastern Europe

--> Asia Pacific

-- >> China

-- >> India

-- >> Japan

-- >> Australia and New Zealand

-- >> Rest of Asia Pacific

--> The Middle-East and Africa

-- >> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

-- >> South Africa

-- >> North Africa

--> Rest of the Middle-East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macroeconomic factors and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390